BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

11845 related articles for article (PubMed ID: 11258774)

  • 1. Risk factors for nodal recurrence after lymphadenectomy for melanoma.
    Pidhorecky I; Lee RJ; Proulx G; Kollmorgen DR; Jia C; Driscoll DL; Kraybill WG; Gibbs JF
    Ann Surg Oncol; 2001 Mar; 8(2):109-15. PubMed ID: 11258774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.
    Lee RJ; Gibbs JF; Proulx GM; Kollmorgen DR; Jia C; Kraybill WG
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):467-74. PubMed ID: 10661355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.
    Fisher SR
    Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma.
    Essner R; Conforti A; Kelley MC; Wanek L; Stern S; Glass E; Morton DL
    Ann Surg Oncol; 1999; 6(5):442-9. PubMed ID: 10458681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
    Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
    Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients.
    Slingluff CL; Stidham KR; Ricci WM; Stanley WE; Seigler HF
    Ann Surg; 1994 Feb; 219(2):120-30. PubMed ID: 8129482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elective and therapeutic regional lymph node dissection for cutaneous malignant melanoma: experience of the British Columbia Cancer Agency, 1972 to 1981.
    Carmichael VE; Robins RE; Wilson KS
    Can J Surg; 1992 Dec; 35(6):600-4. PubMed ID: 1458385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of Recurrence in Patients with Stage IIIB/C Cutaneous Melanoma of the Head and Neck Following Surgery With and Without Adjuvant Radiation Therapy: Is Isolated Regional Recurrence Salvageable?
    Barbour S; Mark Smithers B; Allan C; Bayley G; Thomas J; Foote M; Burmeister B; Barbour AP
    Ann Surg Oncol; 2015 Nov; 22(12):4052-9. PubMed ID: 25582744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can elective lymph node dissection decrease the frequency and mortality rate of late melanoma recurrences?
    Shen P; Guenther JM; Wanek LA; Morton DL
    Ann Surg Oncol; 2000 Mar; 7(2):114-9. PubMed ID: 10761789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI; Rutkowski P; Michej W
    Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep lymph node metastases in the groin significantly affects prognosis, particularly in sentinel node-positive melanoma patients.
    Niebling MG; Wevers KP; Suurmeijer AJ; van Ginkel RJ; Hoekstra HJ
    Ann Surg Oncol; 2015 Jan; 22(1):279-86. PubMed ID: 25008028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases.
    Zdzienicki M; Rutkowski P; Nowecki ZI; van Akkooi AC; Michej W; Dziewirski W; Świtaj T; Pieńkowski A; Sałamacha M; Bylina E; Eggermont AM
    Eur J Surg Oncol; 2013 Mar; 39(3):304-10. PubMed ID: 23298828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma patients with an unknown primary tumor site have a better outcome than those with a known primary following therapeutic lymph node dissection for macroscopic (clinically palpable) nodal disease.
    van der Ploeg AP; Haydu LE; Spillane AJ; Scolyer RA; Quinn MJ; Saw RP; Shannon KF; Stretch JR; Thompson JF
    Ann Surg Oncol; 2014 Sep; 21(9):3108-16. PubMed ID: 24802907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node dissection for clinically evident lymph node metastases of malignant melanoma.
    Meyer T; Merkel S; Göhl J; Hohenberger W
    Eur J Surg Oncol; 2002 Jun; 28(4):424-30. PubMed ID: 12099654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Principles of sentinel lymph node identification: background and clinical implications.
    Cochran AJ; Essner R; Rose DM; Glass EC
    Langenbecks Arch Surg; 2000 Jul; 385(4):252-60. PubMed ID: 10958508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic lymph node dissection in melanoma: different prognosis for different macrometastasis sites?
    Wevers KP; Bastiaannet E; Poos HP; van Ginkel RJ; Plukker JT; Hoekstra HJ
    Ann Surg Oncol; 2012 Nov; 19(12):3913-8. PubMed ID: 22588472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous malignant melanoma of the head and neck.
    Fisher SR
    Laryngoscope; 1989 Aug; 99(8 Pt 1):822-36. PubMed ID: 2755292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of routine ilioinguinal lymph node dissection for palpable inguinal melanoma nodal metastasis.
    Glover AR; Allan CP; Wilkinson MJ; Strauss DC; Thomas JM; Hayes AJ
    Br J Surg; 2014 Jun; 101(7):811-9. PubMed ID: 24752717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.
    Doubrovsky A; De Wilt JH; Scolyer RA; McCarthy WH; Thompson JF
    Ann Surg Oncol; 2004 Sep; 11(9):829-36. PubMed ID: 15313732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel-node biopsy or nodal observation in melanoma.
    Morton DL; Thompson JF; Cochran AJ; Mozzillo N; Elashoff R; Essner R; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Glass EC; Wang HJ;
    N Engl J Med; 2006 Sep; 355(13):1307-17. PubMed ID: 17005948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 593.